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Memo
To:        JID Readers
From:  David A. Schwartz, MD, Director, National Institute of Environmental Health Sciences 
Re:       The Environment and Human Health
Almost every human disease is influenced or caused by an environmental expo-sure. In fact, the National Institute of 
Environmental Health Sciences (NIEHS) was 
established by the United States Congress in 1969 
to reduce the burden of disease by focusing on 
environmental exposures that are involved in 
disease pathogenesis. Consequently, our vision 
at the NIEHS is to prevent disease and improve 
human health by using environmental sciences to 
understand human biology and human disease.
However, the relationship between environ-
mental exposures and human health is com-
plex. Environmental exposures may adversely 
affect those who are vulnerable temporally (age, 
developmental stage), spatially (geographic 
location), and by unique circumstance (comor-
bid disease, nutritional status, socioeconomic 
status, genetics). Understanding the complex 
relationship between endogenous and exoge-
nous risks within populations and affected indi-
viduals, how environmental exposures affect 
human biology, and how this knowledge can be 
used to reduce morbidity and extend longevity 
is precisely the opportunity and challenge faced 
by the NIEHS. To capitalize on this opportunity, 
we have focused programmatic attention in the 
following areas.
Integrated (or translational) research
The field of environmental health sciences — like 
no other field — is not limited by an organ sys-
tem, a methodological discipline, a disease, or a 
population and is therefore by nature interdisci-
plinary. Considering the successes at the NIEHS, 
we have made enormous contributions to bio-
medical research in both fundamental biology 
and public health. For instance, our contributions 
in basic biology (genotoxicity, endocrine disrup-
tor biology, cell signaling, and oxidative stress), as 
well as our contributions in public health (mor-
bidity and mortality of air pollution, lead and IQ, 
and arsenic and cancer), represent very substan-
tial accomplishments by NIEHS investigators. 
However, our contributions to the understanding 
of human disease have not been nearly enough.
With the sequencing of the human genome, 
the sequencing of the genomes of many model 
organisms, and the technological tools that are 
only now available, investigators can bring fun-
damental biological approaches to the bedside 
and can incorporate these technological advanc-
es into epidemiological studies. In environmen-
tal health sciences, we have the opportunity, 
and the responsibility, to understand how basic 
biological processes relate to the risk of develop-
ing disease, and specifically how environmental 
exposures can uniquely inform this process.
However, advances in integrative (or transla-
tional) research in environmental health scienc-
es will require dedication to a new way of think-
ing, and the development of opportunities, infra-
structure, and incentives that are sorely needed 
in our academic communities. At the NIEHS, 
we have initiated a focused approach to this 
new field of science by developing an Office of 
Translational Biomedicine and have developed 
new opportunities in integrated research among 
extramural and intramural scientists (the Disease 
Investigation for Specialized Clinically Oriented 
Ventures in Environmental Research (DISCOVER) 
Program and the Director’s Challenge, respec-
tively). In addition, we have decided to establish 
a Clinical Research Unit within the Division of 
Intramural Research at the NIEHS. The Clinical 
Research Unit will be located on our campus at 
the NIEHS to afford the physician-scientist every 
opportunity to collaborate with basic and pub-
lic health scientists. This will also enable our 
intramural scientists to take an interdisciplin-
ary approach to broad themes in environmen-
tal health that cross methodological disciplines, 
such as reproductive health and epigenetics, 
neurosciences, immune-mediated diseases, and 
metabolism. The goal of this effort is to integrate 
basic, clinical, and public health science to have 
the biggest impact on human health.
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Environmental genomics
A growing body of research helps to illustrate the opportuni-
ties and challenges that lie before us. The influence of envi-
ronmental exposures on transcriptional regulation of genes 
is clearly highlighted by the field of epigenetics. Michael 
Skinner at Washington State University and his colleagues 
recently demonstrated the potential transgenerational 
adverse effects of intrauterine exposure to endocrine-disrupt-
ing pesticides on male fertility (Anway et al., 2005). Findings 
from Randy Jirtle’s laboratory at Duke University indicate 
that exposure through maternal diet to common methylating 
agents found in vegetables and vitamin supplements can have 
profound effects on gene expression in offspring that contin-
ue to be inherited in subsequent generations (Waterland and 
Jirtle, 2003). Moreover, since monozygotic twins diverge in 
the concordance of methylation as a function of age (Fraga et 
al., 2005), it is abundantly clear that methylation is a dynam-
ic process. These findings underscore the role that intrauter-
ine and post-gestational exposures could potentially have 
in common complex diseases that involve developmentally 
vulnerable organ systems. Such research also indicates that 
environmental exposures may serve as biological clues to 
understand the regulation of gene expression and the role 
that transcriptional regulation may play in the risk of devel-
oping disease, as well as pointing to novel therapeutic inter-
ventions.
Environmental exposures can also be used to simplify com-
plex biological processes to both discover unique biological 
mechanisms and narrow the pathophysiological phenotype of 
complex human diseases. For instance, the discovery of the 
aryl hydrocarbon receptor (AHR) occurred as a direct result of 
knowledge of the toxicity of dioxin and polycyclic aromatic 
hydrocarbons. Not only did this discovery demonstrate the 
biological role of the AHR in mediating the toxicity of these 
agents, but it revealed the role of the AHR in homeostatic 
and basic pathophysiological processes. Most importantly, 
however, the identification of the AHR led to the ultimate 
discovery of the PAS (PER-ARNT-SIMS) superfamily of recep-
tors that mediate response to various forms of environmental 
stress such as hypoxemia and circadian rhythm and control 
basic physiological activities such as vascular development, 
learning, and neurogenesis (Kewley et al., 2004; Nebert et al., 
2004). Likewise, understanding of environmental exposures 
can simplify complex disease processes by narrowing the 
pathophysiological phenotype to elucidate the genetics and 
biology that underlie a particular condition. For example, dis-
eases such as asthma arise from dozens of etiologic agents. 
Because asthma caused, or exacerbated, by dust mites, 
endotoxin, or ozone involves different genes and different 
biological mechanisms, the disease can be better studied by 
investigation that focuses on a specific etiologic type.
Given that an extensive number of animal genomes have 
been sequenced and have demonstrated the evolutionary 
conservation of biology and genetic structure, comparative 
genomics will be an important tool for identifying the genes 
that control response to specific environmental agents, which 
in turn will accelerate our discoveries in environmental 
health science. For instance, the discovery of the importance 
of the toll-like receptors in innate immunity in mammals 
occurred as a direct result of the observation that a defective 
receptor in flies caused them to be much more susceptible 
to Aspergillus fumigatus (Lemaitre et al., 1996; Medzhitov 
et al., 1997). The ease with which we can observe and apply 
knowledge across model systems must be exploited so that 
we can efficiently understand the biological and clinical 
importance of environmentally responsive genes.
More precise measures of environmental exposures are needed
Traditional methods of human exposure assessment involve 
measuring exposure concentrations in the ambient environ-
ment and extrapolating to potential points of human con-
tact, and measuring the concentration of parent compounds 
or their metabolites in biological samples (that is, biomoni-
toring). However, these methods are each problematic: 
measures of the ambient environment represent only rough 
estimates of an individual’s exposures, and biomonitoring 
provides only transient estimates of exposure.
We believe the time is right to advance a new science 
focused on the interface between exposures and human 
health. Technologies currently exist for the global analy-
sis of genetic variation, gene transcripts (transcriptomics), 
proteins (proteomics), and metabolites (metabolomics). 
Emerging fields such as medical imaging, nanotechnology, 
and sensor technology are beginning to produce tools that 
affect the way we live and are proving useful in homeland 
security and biodefense. Our view is that these technolo-
gies also represent important opportunities to provide tools 
that could advance our understanding of disease etiology 
by offering quantitative methods to assess the temporal and 
biological response to multiple environmental exposures. 
Ideally, these new technologies will generate insight into 
exposures across the exposure–disease continuum, from the 
point of human contact to the internal dose to the early bio-
logical response (Figure 1).
Fundamental to our vision at NIEHS is the ability to quan-
tify an individual’s exposure, as well as the unique character-
istics that account for individualized responses to common 
exposures. To achieve these goals, we will have to develop an 
exposure biology program that will provide a similiar degree 
of person-to-person precision that is achieved through the 
sequencing of the human genome. This will not be easy, but 
Figure 1. Conceptual approach to environmental biology. The figure 
highlights the opportunities to develop more precise measures of 
environmental exposures and to further characterize the specific biological 
response that links the exposure to the disease process.
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the impact of this scientific infrastructure on advancing our 
understanding of disease etiology and pathogenesis will be 
profound. In the absence of this infrastructure, it will remain 
difficult to evaluate the relationship between environmen-
tal exposures and human health. To the extent feasible, new 
technological developments should complement ongoing 
efforts in the public and private sectors, such as biodefense 
and national health surveillance.
Training
Training the next generation of scientists is one of the most 
important challenges before us. However, many of our current 
trainees may not be equipped to deal with the research oppor-
tunities and challenges in environmental health sciences. We 
believe that there is a critical need to find ways to attract more 
of the best and brightest young people to our field and pro-
vide continued support to trainees during times of transition. If 
we can do this, it will serve to support an integrated research 
approach that encourages disease-oriented research.
I believe that physician-scientists represent an endan-
gered species in biomedical research, but that they are abso-
lutely essential to achieving our vision for the NIEHS. As a 
physician-scientist, my thoughts on this topic may be some-
what biased, but several others (Goldstein and Brown, 1997; 
Ley and Rosenberg, 2005; Rosenberg, 2000; Wyngaarden, 
1979; Zerhouni, 2005) have also raised concerns about the 
fragile future of our species. I sincerely believe that our field 
will benefit enormously by expanding its cadre of physi-
cians committed to the science of environmental health. The 
physician-scientist can help to identify the major opportuni-
ties in biomedical research that are likely to have the big-
gest impact on human health. Moreover, physicians bring 
the bedside to the science through their experiences, such 
as a clear memory of a patient who responded in an unusual 
way. In this context, physicians have the unique ability to 
focus their research on scientific questions that are clinically 
relevant. Although physician-scientists may lead teams of 
basic or public health investigators, they just as often serve 
as the “glue” that holds together the group’s interest in clini-
cally relevant areas of human pathophysiology. However, 
the physician-scientist is not enough. As we shift the focus of 
research supported by the NIEHS to emphasize human dis-
ease, the need for physician-scientists and PhDs focusing on 
the biology of human disease becomes compelling.
To accomplish this, we are in the process of developing a 
number of extramural and intramural programs that focus on 
training, career development, and independent research sup-
port. For instance, we have reengineered our training programs 
to emphasize interdisciplinary research, have initiated a K–12 
training program to support MDs and PhDs as they progress 
from being trainees to being young faculty, and have devel-
oped a combined MD/PhD medical scientist training program 
in environmental health. We have also recently established the 
Outstanding New Environmental Scientist Award, which will 
fund first-time recipients of RO1 grants who are using environ-
mental science to understand a human disease.
Our view of environmental health sciences is of an over-
arching discipline that addresses etiologic considerations 
that are common to many, if not all, of the diseases people 
face. Environmental health sciences must play a more cen-
tral role in understanding how genes work in biological 
systems, how genetic variants contribute to the develop-
ment of disease, and why individuals with the same dis-
ease have very different clinical outcomes. Our scientists 
and our knowledge of environmental health sciences are 
absolutely vital to the understanding of human biology and 
human disease. In fact, I fully believe that we represent the 
critical link between exposures and biological responses that 
is necessary for the understanding of many different diseases. 
If we keep our eyes firmly fixed on our goal of understand-
ing human disease and improving human health, it is clear 
to me that our discipline will remain essential to progress in 
many fields of biomedical research and will ultimately con-
tribute to advances in reducing the burden of disease and 
extending survival.
David A. Schwartz, MD1
Director, NIEHS and National Toxicology Program
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